Daniel Hunt

Vice President, Corporate & Business Development

Professional Overview
Daniel Hunt is an accomplished executive with extensive experience in corporate and business development, particularly within the biotechnology and life sciences industries. As the Vice President of Corporate & Business Development at Allogene Therapeutics, he plays a pivotal role in driving the company's strategic growth initiatives and forging valuable partnerships.

Experience Summary

Current Role
In his current role at Allogene Therapeutics, Daniel is responsible for leading the company's corporate development activities, including mergers, acquisitions, licensing, and strategic alliances. He works closely with the executive team to identify and evaluate new business opportunities that align with Allogene's long-term vision and goals. Under his guidance, the company has successfully completed several high-impact transactions, expanding its pipeline and enhancing its technological capabilities.

Career Progression
Prior to joining Allogene, Daniel served as the Vice President of Corporate Development at Fluidigm Corporation, where he played a crucial role in shaping the company's growth strategy and executing key partnerships. He has also held board positions at Overland Therapeutics, Notch Therapeutics, and Antion Biosciences SA, providing strategic guidance and oversight to these innovative biotechnology companies.

Academic Background
Daniel holds a Bachelor of Science degree from the University of California, Berkeley, where he specialized in Molecular and Cell Biology. His academic excellence and passion for the life sciences laid the foundation for his successful career in the industry.

Areas of Expertise

• Corporate and business development strategy

• Mergers, acquisitions, and strategic alliances

• Licensing and partnership negotiations

• Pipeline and portfolio optimization

• Cross-functional leadership and collaboration

Professional Impact
Throughout his career, Daniel has played a pivotal role in shaping the growth and development of several biotechnology companies. His strategic vision, deal-making expertise, and deep industry knowledge have enabled him to secure transformative partnerships and drive the successful expansion of the companies he has served. By leveraging his strong network and extensive experience, Daniel continues to make significant contributions to the advancement of novel therapies and technologies in the life sciences sector.

Conclusion
With his proven track record of success, Daniel Hunt is a respected and influential leader in the biotechnology industry. As the Vice President of Corporate & Business Development at Allogene Therapeutics, he is well-positioned to continue driving the company's growth and expanding its impact on the lives of patients worldwide.